Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Aaron J Scott, Rodabe N Amaria & Karl Lewis. (2011) Adjuvant peginterferon alfa-2b therapy in stage III melanoma. Expert Review of Dermatology 6:6, pages 567-575.
Read now
Read now
Jonathan D. Schoenfeld & Glenn Dranoff. (2011) Anti-angiogenesis immunotherapy. Human Vaccines 7:9, pages 976-981.
Read now
Read now
Shanthi Sivendran, Michael Pan, Howard L Kaufman & Yvonne Saenger. (2010) Herpes simplex virus oncolytic vaccine therapy in melanoma. Expert Opinion on Biological Therapy 10:7, pages 1145-1153.
Read now
Read now
Thiruma V Arumugam, Pradeep K Selvaraj, Trent M Woodruff & Mark P Mattson. (2008) Targeting ischemic brain injury with intravenous immunoglobulin. Expert Opinion on Therapeutic Targets 12:1, pages 19-29.
Read now
Read now
Articles from other publishers (35)
Riccardo PAMPENA, Simone MICHELINI, Michela LAI, Johanna CHESTER, Giovanni PELLACANI & Caterina LONGO. (2021) New systemic therapies for cutaneous melanoma: why, who and what. Italian Journal of Dermatology and Venereology 156:3.
Crossref
Crossref
Jamie A. G. Hamilton, Miyoung Y. Lee, Rae Hunter, Raira S. Ank, Jamie Y. Story, Ganesh Talekar, Talia Sisroe, Dov B. Ballak, Andrew Fedanov, Christopher C. Porter, Elan Z. Eisenmesser, Charles A. Dinarello, Sunil S. Raikar, James DeGregori & Curtis J. Henry. (2021) Interleukin‐37 improves T‐cell‐mediated immunity and chimeric antigen receptor T‐cell therapy in aged backgrounds. Aging Cell 20:2.
Crossref
Crossref
Naser Babaei & Metin U. Salamci. (2019) Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control. European Journal of Control 50, pages 117-137.
Crossref
Crossref
Mohamed L. Salem, Soha G.R. Abdel Salam, Mohamed Nassef, Said Hammad & Rania El Adl. (2015) Immunoenhancing properties of the anti-tumor effects of adoptively transferred T cells with chemotherapeutic cyclophosphamide by co-administration of bone marrow cells. The Journal of Basic & Applied Zoology 72, pages 96-103.
Crossref
Crossref
Natacha Bordry, Carla-Marisa Costa-Nunes, Laurène Cagnon, Philippe O. Gannon, Samia Abed-Maillard, Petra Baumgaertner, Timothy Murray, Igor Letovanec, Romain Lazor, Hasna Bouchaab, Nathalie Rufer, Emanuela Romano, Olivier Michielin & Daniel E. Speiser. (2014) Pulmonary Sarcoid–like Granulomatosis after Multiple Vaccinations of a Long-term Surviving Patient with Metastatic Melanoma. Cancer Immunology Research 2:12, pages 1148-1153.
Crossref
Crossref
David M. Foureau, Asim Amin, Richard L. White, William Anderson, Chase P. Jones, Terry Sarantou, Iain H. McKillop & Jonathan C. Salo. (2014) Sequential immune monitoring in patients with melanoma and renal cell carcinoma treated with high-dose interleukin-2: immune patterns and correlation with outcome. Cancer Immunology, Immunotherapy 63:12, pages 1329-1340.
Crossref
Crossref
Juhua Zhou. (2014) Advances and Prospects in Cancer Immunotherapy. New Journal of Science 2014, pages 1-13.
Crossref
Crossref
Shanthi Sivendran, Joe Goldufsky, Howard Kaufman & Yvonne Saenger. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer
213
223
.
Olatz Crende, Marianna Sabatino, María Valcárcel, Teresa Carrascal, Pia Riestra, Jose A. López-Guerrero, Eduardo Nagore, Susanna Mandruzzato, Ena Wang, Francesco M. Marincola & Fernando Vidal-Vanaclocha. (2013) Metastatic Lesions with and without Interleukin-18–Dependent Genes in Advanced-Stage Melanoma Patients. The American Journal of Pathology 183:1, pages 69-82.
Crossref
Crossref
B. Leticia Rodriguez, Jorge M. Blando, Dharmika S. P. Lansakara-P, Yuriko Kiguchi, John DiGiovanni & Zhengrong Cui. (2013) Antitumor Activity of Tumor-Targeted RNA Replicase-Based Plasmid That Expresses Interleukin-2 in a Murine Melanoma Model. Molecular Pharmaceutics 10:6, pages 2404-2415.
Crossref
Crossref
Yasuhiro Fujisawa & Fujio Otsuka. (2012) The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma. Melanoma Research 22:5, pages 362-367.
Crossref
Crossref
Russell R. Braeuer, Einav Shoshan, Takafumi Kamiya & Menashe Bar-Eli. (2012) The sweet and bitter sides of galectins in melanoma progression. Pigment Cell & Melanoma Research 25:5, pages 592-601.
Crossref
Crossref
Daniel F. Dilling, Emily R. Gilbert, Maria M. Picken, Jonathan M. Eby, Robert B. Love & I. Caroline Le Poole. (2012) A Current Viewpoint of Lymphangioleiomyomatosis Supporting Immunotherapeutic Treatment Options. American Journal of Respiratory Cell and Molecular Biology 46:1, pages 1-5.
Crossref
Crossref
David M. Foureau, Iain H. McKillop, Chase P. Jones, Asim Amin, Richard L. White & Jonathan C. Salo. (2011) Skin tumor responsiveness to interleukin-2 treatment and CD8 Foxp3+ T cell expansion in an immunocompetent mouse model. Cancer Immunology, Immunotherapy 60:9, pages 1347-1356.
Crossref
Crossref
Haipeng Liu, Brandon Kwong & Darrell J. Irvine. (2011) Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy. Angewandte Chemie International Edition 50:31, pages 7052-7055.
Crossref
Crossref
Haipeng Liu, Brandon Kwong & Darrell J. Irvine. (2011) Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy. Angewandte Chemie 123:31, pages 7190-7193.
Crossref
Crossref
Russell R. Lonser, Debbie K. Song, Jacob Klapper, Marygrace Hagan, Sungyoung Auh, P. Benjamin Kerr, Deborah E. Citrin, John D. Heiss, Kevin Camphausen & Steven A. Rosenberg. (2011) Surgical management of melanoma brain metastases in patients treated with immunotherapy. Journal of Neurosurgery 115:1, pages 30-36.
Crossref
Crossref
Adrian Bot. 2011. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures. Cancer Management in Man: Chemotherapy, Biological Therapy, Hyperthermia and Supporting Measures
237
244
.
Stephen J. Beebe, Karl H. Schoenbach & Richard Heller. (2010) Bioelectric Applications for Treatment of Melanoma. Cancers 2:3, pages 1731-1770.
Crossref
Crossref
Annarosa Arcangeli, Lucio Toma, Luca Contiero, Olivia Crociani, Laura Legnani, Carlotta Lunghi, Elisa Nesti, Gloriano Moneti, Barbara Richichi & Cristina Nativi. (2010)
Stable GM
3
Lactone Mimetic Raises Antibodies Specific for the Antigens Expressed on Melanoma Cells
. Bioconjugate Chemistry 21:8, pages 1432-1438.
Crossref
Crossref
Howard L KaufmanSteven D Bines. (2010) OPTIM trial: a Phase III trial of an oncolytic herpes virus encoding GM-CSF for unresectable stage III or IV melanoma. Future Oncology 6:6, pages 941-949.
Crossref
Crossref
Sven Stengel, Uwe Fiebig, Reinhard Kurth & Joachim Denner. (2010) Regulation of human endogenous retrovirus‐K expression in melanomas by CpG methylation. Genes, Chromosomes and Cancer 49:5, pages 401-411.
Crossref
Crossref
Neil N. SenzerHoward L. KaufmanThomas AmatrudaMike NemunaitisTony ReidGregory DanielsRene GonzalezJohn GlaspyEric WhitmanKevin HarringtonHoward GoldsweigTracey MarshallColin LoveRobert CoffinJohn J. Nemunaitis. (2009) Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. Journal of Clinical Oncology 27:34, pages 5763-5771.
Crossref
Crossref
Scott Ely. (2009) Personalized medicine: individualized care of cancer patients. Translational Research 154:6, pages 303-308.
Crossref
Crossref
William K. Decker & Amar Safdar. (2009) Bioimmunoadjuvants for the treatment of neoplastic and infectious disease: Coley's legacy revisited. Cytokine & Growth Factor Reviews 20:4, pages 271-281.
Crossref
Crossref
Tim Eisen, José Thomas, Wilson H. Miller, Martin Gore, Pascal Wolter, Petr Kavan, José A. López Martín & Pilar Lardelli. (2009) Phase II study of biweekly plitidepsin as second-line therapy in patients with advanced malignant melanoma. Melanoma Research 19:3, pages 185-192.
Crossref
Crossref
Joel M. Baumgartner, Rene Gonzalez, Karl D. Lewis, William A. Robinson, Don A. Richter, Brent E. Palmer, Cara C. Wilson & Martin D. McCarter. (2009) Increased Survival From Stage IV Melanoma Associated With Fewer Regulatory T Cells. Journal of Surgical Research 154:1, pages 13-20.
Crossref
Crossref
Edoardo Zattra, Anna Belloni Fortina, Matteo Bordignon, Stefano Piaserico & Mauro Alaibac. (2009) Immunosuppression and melanocyte proliferation. Melanoma Research 19:2, pages 63-68.
Crossref
Crossref
Van Anh Trinh & Jamie Poust. (2008) Introduction. American Journal of Health-System Pharmacy 65:24_Supplement_9, pages S1-S2.
Crossref
Crossref
Van Anh Trinh. (2008) Continuing Education. American Journal of Health-System Pharmacy 65:24_Supplement_9, pages S16-S17.
Crossref
Crossref
Rahul Palchaudhuri & Paul J. Hergenrother. (2008) Triphenylmethylamides (TPMAs): Structure–activity relationship of compounds that induce apoptosis in melanoma cells. Bioorganic & Medicinal Chemistry Letters 18:22, pages 5888-5891.
Crossref
Crossref
Klaus Stensgaard Frederiksen, Dorthe Lundsgaard, Jeremy A. Freeman, Steven D. Hughes, Thomas L. Holm, Birte K. Skrumsager, Andreas Petri, Lasse T. Hansen, Grant A. McArthur, Ian D. Davis & Kresten Skak. (2008) IL-21 induces in vivo immune activation of NK cells and CD8+ T cells in patients with metastatic melanoma and renal cell carcinoma. Cancer Immunology, Immunotherapy 57:10, pages 1439-1449.
Crossref
Crossref
F Errington, C L White, K R Twigger, A Rose, K Scott, L Steele, L J Ilett, R Prestwich, H S Pandha, M Coffey, P Selby, R Vile, K J Harrington & A A Melcher. (2008) Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Therapy 15:18, pages 1257-1270.
Crossref
Crossref
. (2008) Current World Literature. Current Opinion in Oncology 20:2, pages 234-244.
Crossref
Crossref
Niramol SavarajChunjing WuMarcus Tien KuoMin YouMedhi WangpaichitrCarlos RoblesSeth SpectorLynn Feun. (2017) The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma. Drug Target Insights 2, pages 117739280700200.
Crossref
Crossref